The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice.

MLA

de Jong, Amos J., et al. “The Impact of Operational Trial Approaches on Representativeness: Comparison of Decentralized Clinical Trial Participants, Conventional Trial Participants, and Patients in Daily Practice.” Drug Discovery Today, vol. 30, no. 2, Jan. 2025, p. 104304. EBSCOhost, https://doi.org/10.1016/j.drudis.2025.104304.

APA

de Jong, A. J., Zuidgeest, M. G. P., Santa-Ana-Tellez, Y., Hallgreen, C. E., van Sloten, T. T., de Boer, A., & Gardarsdottir, H. (2025). The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice. Drug Discovery Today, 30(2), 104304. https://doi.org/10.1016/j.drudis.2025.104304

Chicago

de Jong, Amos J, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, Christine E Hallgreen, Thomas T van Sloten, Anthonius de Boer, and Helga Gardarsdottir. 2025. “The Impact of Operational Trial Approaches on Representativeness: Comparison of Decentralized Clinical Trial Participants, Conventional Trial Participants, and Patients in Daily Practice.” Drug Discovery Today 30 (2): 104304. doi:10.1016/j.drudis.2025.104304.